|
ZNF398 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.968400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.372200E-04 |
| Normal-vs-Stage2 |
1.671050E-01 |
| Normal-vs-Stage3 |
7.590400E-04 |
| Normal-vs-Stage4 |
1.983460E-04 |
| Stage1-vs-Stage2 |
1.290160E-01 |
| Stage1-vs-Stage3 |
9.474400E-01 |
| Stage1-vs-Stage4 |
2.542400E-01 |
| Stage2-vs-Stage3 |
1.261830E-01 |
| Stage2-vs-Stage4 |
3.889600E-02 |
| Stage3-vs-Stage4 |
3.596800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.413400E-04 |
| Normal-vs-AfricanAmerican |
1.115970E-01 |
| Normal-vs-Asian |
1.981900E-03 |
| Caucasian-vs-AfricanAmerican |
4.093600E-01 |
| Caucasian-vs-Asian |
8.242200E-01 |
| AfricanAmerican-vs-Asian |
3.498600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.478700E-03 |
| Normal-vs-Female |
5.022300E-04 |
| Male-vs-Female |
4.094400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.159300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.415700E-04 |
| Normal-vs-Age(61-80Yrs) |
7.595500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.008820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.255800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.570800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.303600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.883400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.000000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.025200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.564400E-02 |
| Classical-VS-Follicular |
9.304300E-02 |
| Classical-VS-Other |
1.230400E-01 |
| Classical-VS-Normal |
6.044000E-03 |
| Tall-VS-Follicular |
4.650600E-01 |
| Tall-VS-Other |
6.099400E-01 |
| Tall-VS-Normal |
2.369800E-04 |
| Follicular-VS-Other |
4.062800E-01 |
| Follicular-VS-Normal |
5.021000E-04 |
| Other-VS-Normal |
2.836300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.238600E-04 |
| Normal-vs-N1 |
3.79550000000339E-05 |
| N0-vs-N1 |
4.367600E-02 |
|
|
